WESTFIELD CAPITAL MANAGEMENT CO LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
WESTFIELD CAPITAL MANAGEMENT CO LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$3,140,753
-67.5%
253,491
-72.8%
0.02%
-68.8%
Q3 2022$9,663,000
-63.8%
932,769
-59.7%
0.08%
-63.3%
Q2 2022$26,705,000
-75.1%
2,316,128
-72.9%
0.21%
-69.5%
Q1 2022$107,363,000
+13.0%
8,534,416
+4.8%
0.69%
+21.8%
Q4 2021$94,979,000
-11.1%
8,145,674
-0.4%
0.56%
-12.3%
Q3 2021$106,844,000
+32.6%
8,181,003
+30.7%
0.64%
+33.6%
Q2 2021$80,552,000
+33.8%
6,258,873
+16.3%
0.48%
+28.9%
Q1 2021$60,189,000
-37.7%
5,383,650
-36.6%
0.37%
-34.8%
Q4 2020$96,679,000
+57.0%
8,488,042
+24.0%
0.57%
+43.9%
Q3 2020$61,581,000
+11.7%
6,846,192
+28.2%
0.40%
+5.3%
Q2 2020$55,121,000
+14.2%
5,341,204
+11.6%
0.38%
-10.8%
Q1 2020$48,282,000
+48.8%
4,785,126
+96.3%
0.42%
+84.0%
Q4 2019$32,438,000
+49.8%
2,437,096
-3.4%
0.23%
+33.5%
Q3 2019$21,656,000
-17.3%
2,522,489
+5.4%
0.17%
-12.2%
Q2 2019$26,177,000
+2.8%
2,392,774
+27.1%
0.20%
+1.5%
Q1 2019$25,462,000
+24.4%
1,881,874
-4.7%
0.19%
+10.9%
Q4 2018$20,460,000
-41.0%
1,974,879
+5.1%
0.18%
-28.3%
Q3 2018$34,683,000
+30.3%
1,878,809
+34.9%
0.24%
+22.6%
Q2 2018$26,619,0001,392,2310.20%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders